ArticleBMJ open2020

Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial.

Michael J R Desborough et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.